Harrow, Inc. Operating Leases, Rent Expense
Harrow, Inc. (HROW) reported Operating Leases, Rent Expense of $276.42 thousand for the 173-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2013-03-18
- Harrow, Inc. operating leases, rent expense for fiscal 2012 was $32.47K, a 77.42% increase from fiscal 2011.
- Harrow, Inc. operating leases, rent expense for fiscal 2011 was $18.30K.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 173 month |
|---|---|---|
| 2012-12-31 | $32.47K 10-K · filed 2013-03-18 | $276.42K 10-K · filed 2013-03-18 |
| 2011-12-31 | $18.30K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |